BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11504823)

  • 1. Ovarian sex steroid-dependent plasticity of nociceptin/orphanin FQ and opioid modulation of spinal dynorphin release.
    Gupta DS; Kelson AB; Polgar WE; Toll L; Szücs M; Gintzler AR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1213-20. PubMed ID: 11504823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ovarian sex steroids on spinal methionine-enkephalin release: comparison with dynorphin reveals asymmetrical regulation.
    Gupta DS; Gintzler AR
    J Pharmacol Exp Ther; 2003 Feb; 304(2):738-44. PubMed ID: 12538829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment.
    Zhang Y; Donica CL; Standifer KM
    Neuropharmacology; 2012 Sep; 63(3):427-33. PubMed ID: 22575074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17 beta-estradiol and progesterone positively modulate spinal cord dynorphin: relevance to the analgesia of pregnancy.
    Medina VM; Dawson-Basoa ME; Gintzler AR
    Neuroendocrinology; 1993 Sep; 58(3):310-5. PubMed ID: 7902960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
    J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord.
    Yamada S; Kusaka T; Urayama A; Kimura R; Watanabe Y
    Br J Pharmacol; 2003 Aug; 139(8):1462-8. PubMed ID: 12922933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.
    Albrecht E; Samovilova NN; Oswald S; Baeger I; Berger H
    J Pharmacol Exp Ther; 1998 Aug; 286(2):896-902. PubMed ID: 9694948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of prohormone convertase 2 in spinal cord during gestation and hormone-simulated pregnancy.
    Varshney C; Rivera M; Gintzler AR
    Neuroendocrinology; 1999 Oct; 70(4):268-79. PubMed ID: 10529622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ.
    Berger H; Albrecht E; Wallukat G; Bienert M
    Br J Pharmacol; 1999 Feb; 126(3):555-8. PubMed ID: 10188961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin (Orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociception and induces hyperalgesia.
    Dawson-Basoa M; Gintzler AR
    Brain Res; 1997 Mar; 750(1-2):48-52. PubMed ID: 9098528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of opioid receptor like-1 receptor in the spinal cord produces sex-specific antinociception in the rat: estrogen attenuates antinociception in the female, whereas testosterone is required for the expression of antinociception in the male.
    Claiborne J; Nag S; Mokha SS
    J Neurosci; 2006 Dec; 26(50):13048-53. PubMed ID: 17167094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.
    Chen X; McClatchy DB; Geller EB; Liu-Chen L; Tallarida RJ; Adler MW
    Brain Res; 2001 Jun; 904(2):252-8. PubMed ID: 11406123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pronociceptive effects of nociceptin/orphanin FQ (13-17) at peripheral and spinal level in mice.
    Inoue M; Matsunaga S; Rashid MH; Yoshida A; Mizuno K; Sakurada T; Takeshima H; Ueda H
    J Pharmacol Exp Ther; 2001 Oct; 299(1):213-9. PubMed ID: 11561082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
    Lee H
    Yonsei Med J; 2013 May; 54(3):763-71. PubMed ID: 23549827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
    Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
    Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury.
    Kulkarni M; Armstead WM
    J Neurotrauma; 2002 Aug; 19(8):965-73. PubMed ID: 12225656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.
    Fu X; Zhu ZH; Wang YQ; Wu GC
    Neuroscience; 2007 Jan; 144(1):275-85. PubMed ID: 17069983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin/orphanin FQ causes non-quantal slowing of respiratory rhythm in brainstem-spinal cord preparation from newborn rat.
    Takita K; Morimoto Y
    Neurosci Lett; 2008 Oct; 443(3):129-33. PubMed ID: 18694807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.
    Gardell LR; Wang R; Burgess SE; Ossipov MH; Vanderah TW; Malan TP; Lai J; Porreca F
    J Neurosci; 2002 Aug; 22(15):6747-55. PubMed ID: 12151554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.